Dicerna Pharmaceuticals' Series B - II Round

Dicerna Pharmaceuticals raised a round of funding on October 26, 2010. Investors include SR One.

Dicerna Pharmaceuticals is a pharmaceutical company developing RNA interference (RNAi)-based therapeutics against genetically-defined targets in multiple disease areas, including cancer. Dicerna's the…

Articles about Dicerna Pharmaceuticals' Series B - II Round: